Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000564076 | SCV000665109 | likely benign | Hereditary cancer-predisposing syndrome | 2019-09-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000564076 | SCV000691593 | likely benign | Hereditary cancer-predisposing syndrome | 2017-03-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001451701 | SCV001655342 | likely benign | Li-Fraumeni syndrome | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000564076 | SCV002530455 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-05-19 | criteria provided, single submitter | curation |